chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I thought I had a UTI and I started having extreme chills. The chills weren't normal, but it was like someone was shaking my body and it lasted for about 45 min and I took XANAX as soon as I got home, and it did calm the shaking. They tested for the UTI and they said I did have a UTI.
Originally, I started with random muscle aches in my left shoulder then it went down my back (a few hours after receiving vaccine). Then slightly fogginess and at night the muscle pain became worse making it difficult to sleep and started getting cold flashes. Once asleep around 12:30 I started getting muscle aches that felt like they were burning and in random spots on body along with a headache and would get random cold and heat flashes. Kept yelling out in pain all night and increased tremors in hands. Boyfriend noticed I had a fever as well and gave me ibuprofen around 3am since pain was unbearable and was difficult to sleep. Almost took me to the hospital due to the intense pain.. In morning slightly better but still frontal lobe pain and aches throughout body with raised heart rate. Cannot do much or else aches get worse including headache.
TIme of vax 4 hrs p/vax exp red cheeks & ears, hot ears, chills then sweats, blurred vision for 4-7 hrs, fatigue & body aches;
Almost immediately after receiving the first dosage, I developed a left brachial neuritis which is ongoing
This case was reported by a pharmacist via cell center representative and described the occurrence of rash in a 69-year-old female patient who received SHINGRIX (batch number B5EK2, expiry date 28th April 2020). On 14th March 2018, the patient received the 1st dose of SHINGRIX .5 ml. On 16th March 2018, 2 days after receiving SHINGRIX, the patient experienced rash. On an unknown date, the outcome of the rash was unknown. It was unknown if the reporter considered the rash to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the right deltoid. The patient experienced rash on her abdomen that wrapped around to her back.
0850 - Patient reported mouth was dry and throat was tight - was given water.  Patient laid down and fanned to cool off. HR = 98, RR = 16, O2 Sat = 98%.  Face went from red to pink and patient stated she "responds similarly to new things" and this was a "typical reaction".  She has a personal epi pen (not used at this time). 0912 - Patient feeling fine - back to normal.  Patient left clinic.
Broke out in severe rash on 5th day after vaccination. Swollen lips, ears, upper eye lids, under both arms, under breasts and upper thighs. Terribly itchy.  Rash was raised like welts. Got worse the next day and included scalp, neck, hands, forearms and knees. Called my family medicine doc and he called in a script for MethylPredisone.  Took the first 3 pills after lunch as recommended by pharmacist.  Slept through the night and noticed the rash was not as angry looking.  I have continued on my second day doses. Have noticed the itch coming back starting around 4:15 pm today.   Have 3 more doses to take today.
Felt very tired the evening of my 2nd dose of Covid vaccine.  Woke early the next morning (01/08/21) with a high fever, chills, body aches, fatigue.  Fever broke around midnight that night and I felt back to normal around noon the next day.  Overall, I felt unwell for about 48 hours, and very sick for about 18 hours.  I did not medicate for sx as we were advised by the hospital against NSAIDS to maximize antibody production.
Extreme headache daily since first dose of vaccine, two weeks ago today.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 01Apr2021 at 14:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history.  The patient did not receive any medication within two weeks of vaccination. The patient had no known allergies to medications, food and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 16:00, the patient experienced extreme headache daily since first dose of vaccine, two weeks ago today. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. . The patient did not receive any treatment for the reported event. The clinical outcome of the event extreme headache was not recovered.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No medical history or concurrent conditions were reported. The pharmacist reported that the patient was inadvertently administered with an expired dose of M-M-R II. On 19-FEB-2014 the patient was vaccinated with M-M-R II (lot # 1896AA, albumin status HSA) subcutaneously, while the expiration date was 02-DEC-2013. No adverse effects were reported. No further information was provided. Additional information has been requested.
I received the dose on 09/21/2022 and started to experience a sore throat on 10/13/2022. I thought that on 10/14/2022 that I was experiencing allergies with runny nose. On 10/15/2022, I started to have chest congestion. I took at COVID-19 test on 10/16/2022 and I received a positive result. I went to the urgent care on 10/16/2022 and was prescribed PAXLOVID. As of today, I am feeling much better.
tested positive for Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the parent.  A 9 year-old male patient received bnt162b2 (BNT162B2), administration date 01Jan2022 (Batch/Lot number: unknown) as dose 1 (tris), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (non-serious) with onset 09Jan2022, outcome "unknown", described as "tested positive for Covid". Relevant laboratory tests and procedures are available in the appropriate section. Action taken with respect to suspected vaccine is Not applicable.  Additional information: Investigation Assessment is not provided.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I get flu like symptoms after each of my vaccines. I get dizziness, fatigue, muscle weakness, nausea, and lightheadedness. The symptoms subsided after a week. I am weak to medications and I seem to get all sick all the time after medications that my doctor needs to change my blood pressure medication. However, the newest dose the 5th one was Moderna, and that one was not as strong. After the first dose however, I had to see a cardiologist and he had to change my medication, and by the 4th one I had to get different medication completely. All of these were Pfizer, however, the 4th and 5th were Moderna.
Left lower leg swelling which onset Sunday morning after getting his 2nd COVID-19 Vaccine (MODERNA) on Saturday.
shingles; Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. No information was provided regarding medical history, concurrent condition, or concomitant medication. In 2014, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose number and route was not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date (reported as "subsequent to zoster vaccine live (ZOSTAVAX) inoculation"), the patient was treated by a physician for shingles. As a direct and proximate result of the patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
10 days after shot, rash/hives appeared on both arms around my bicep.  Went away and then hives appeared on forearm and crease of elbow. This occurred days 10 through today (day14). Small red raised bumps on my upper back and arm pits. They go away then reappeared. Not bothered by it
Nausea, weakness, headache, itchy head, giant hives head, face, stomach, thighs and legs.
On  August I  had a  neck pain and headache. The headache continued till October. I took Advil .  Around 10/20/2022 I went to the ER because I was experiencing headache and my blood pressure was high. They did some blood tests and said to go to a primary doctor. we did more blood  where they diagnosed me as having Giant Cell Arteritis ( rare disease). My  doctor prescribed Prednisone and Actemra weekly injections. I will  be Seeing the  Rheumatologist   soon  again  June for a follow up.  The disease that I have  cannot be  cured. It can be triggered by medication or infection but not sure where it exactly came from. . In October I had  an infection  (cold) may be It could be from there  who knows. My doctor is not even sure where I developed this disease from.
pt recv vax & 2 1/2hr post vax pt exp hives, itching, red rash (blotches), & SOB;tx w/oral DPH & then was seen in ER;
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 19-DEC-2018, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number R005865 with expiration date in 22-OCT-2019) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA001848: US-009507513-1907USA001849: US-009507513-1906USA011434: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001796: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001825: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA001847: US-009507513-1907USA000952: US-009507513-1907USA000953: US-009507513-1907USA000954: US-009507513-1907USA000959: US-009507513-1907USA000962: US-009507513-1907USA000963: US-009507513-1907USA000964: US-009507513-1907USA000965: US-009507513-1907USA000966: US-009507513-1907USA000967: US-009507513-1907USA000968: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000988: US-009507513-1907USA000989:
Pt. developed a reaction to 1st dose of covid-19 vaccine.   Symptoms described as having a heavy chest, blurred vision, and fatigue.   Pt currently does not have HCP.  States that she has elevated readings daily for her blood sugar, alsostates that she takes a non prescribed medication that she gets from other persons, not HCP or any other healthcare professional.  Vitals: 142/102, 100%, blood sugar 36 mg dl.  Pt. verbalizes that symptoms are still present.  Additional EMS called for transportation to Hospital.  Pt. requested to be transferredto hospital by EMS.
Swelling of the throat; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Swelling of the throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PHARYNGEAL SWELLING (Swelling of the throat). At the time of the report, PHARYNGEAL SWELLING (Swelling of the throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Feb-2021 and was forwarded to Moderna on 26-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Swelling of the throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PHARYNGEAL SWELLING (Swelling of the throat). At the time of the report, PHARYNGEAL SWELLING (Swelling of the throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.
82-yr old female (wt 66.2kg) came to clinic on 6/30/15 for follow-up.   Pneumococcal 13 vaccine 0.5ml IM was given at 0158 by CMA in right deltoid (# Wyeth-Ayerst Lot # L58152, expiration date 11/1/2016).  On 7/8/15, pt called the office to report that she experienced red, raised and itchy area over the right arm where she received the Prevnar injection on 6/30/2015.  Pt came to MD office at 1620 on 7/8/15 for assessment.
On 03/30/2021 prior to the vaccination, I had been on an airplane. I was having a hard time unplugging my ears.  On 04/01/2021 I had my 2nd dose of Pfizer. Around 04/03/2021, I notice my ears started ringing and it did not stop. It was continual ringing and it never stopped. I did not have any other reaction after the shot. I messaged my doctor and she told me to take over-the-counter decongestion.  Around the 05/01/2021, I saw Dr, she encouraged me to continue to take the decongestion, she said I had a little bit of fluid in my ear. The fluid went away after a while. It's been 6 months and the ringing has not gone away.
Patient had a reaction at the injection site. Skin was red, but did not hurt or itch.
Adverse effect of other vaccines and biological substances, initial encounter on 2022-02-10.
pt recv vax 19SEP97 t100 dx as having OM;went to sleep in evening & devel high fever 105;had sz
Pt complains of increasing swelling, redness, aching left upper arm 7 days after receiving Tdap injection. Erythema present, swelling and tenderness from bicep to (L) elbow. Pt given scripts for clindamycin 300mg QID x 10 days and prednisone 5 mg PO Qday x 5 days.
muscles felt weak; muscles felt a bit tender; the left arm felt like it had had a shot, it was a little bit sore; left arm was a little bit swollen; clavicle area started to swelled up on the opposite side from the shot, from the neck all the way down. it was super-swollen.; neck was stiff; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (neck was stiff), SWELLING (clavicle area started to swelled up on the opposite side from the shot, from the neck all the way down. it was super-swollen.), MUSCULAR WEAKNESS (muscles felt weak), MYALGIA (muscles felt a bit tender) and PAIN IN EXTREMITY (the left arm felt like it had had a shot, it was a little bit sore) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine. Concomitant products included TOPIRAMATE (TOPAMAX) for Migraine, BUPROPION HYDROCHLORIDE (WELLBUTRIN) and VITAMINS NOS for an unknown indication.    On 12-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (neck was stiff). On 02-Dec-2021, the patient experienced SWELLING (clavicle area started to swelled up on the opposite side from the shot, from the neck all the way down. it was super-swollen.). On 05-Dec-2021, the patient experienced MUSCULAR WEAKNESS (muscles felt weak), MYALGIA (muscles felt a bit tender), PAIN IN EXTREMITY (the left arm felt like it had had a shot, it was a little bit sore) and PERIPHERAL SWELLING (left arm was a little bit swollen). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (neck was stiff), SWELLING (clavicle area started to swelled up on the opposite side from the shot, from the neck all the way down. it was super-swollen.), MUSCULAR WEAKNESS (muscles felt weak), MYALGIA (muscles felt a bit tender), PAIN IN EXTREMITY (the left arm felt like it had had a shot, it was a little bit sore) and PERIPHERAL SWELLING (left arm was a little bit swollen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood potassium increased: high (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient consulted with their HCP, who indicated a sonogram of the head and neck area.  Patient is scheduled to get the Moderna second dose on Friday 10Dec2021 and wonder if they should get it, wait or not get it at all.
Raised rashes on their feet and legs; This case was reported by a consumer via call center representative and described the occurrence of raised rash in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd August 2020, the patient received the 1st dose of Shingrix (intramuscular). In September 2020, 2 weeks after receiving Shingrix, the patient experienced raised rash. On an unknown date, the outcome of the raised rash was recovered/resolved.   It was unknown if the reporter considered the raised rash to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient himself. The patient received Shingrix in the right arm and about two weeks afterwards developed raised rashes on feet and some areas of their legs.   It would fade then come back and resolved after about four weeks.  The doctor could not say it was related to the Shingrix and given Covid tests but they were negative. The reporter consented to follow up. This case linked with US2020226576, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020226576:Same reporter
6 inch wide rash on the opposite side of the L elbow (volar area); Itchy on the area of the injection; Painful bump/swelling at the injection site; Difficulty moving his L arm up and down; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Difficulty moving his L arm up and down), VACCINATION SITE PRURITUS (Itchy on the area of the injection), VACCINATION SITE SWELLING (Painful bump/swelling at the injection site) and VACCINATION SITE RASH (6 inch wide rash on the opposite side of the L elbow (volar area)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Difficulty moving his L arm up and down) and VACCINATION SITE SWELLING (Painful bump/swelling at the injection site). On 10-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy on the area of the injection). On 11-Jan-2021, the patient experienced VACCINATION SITE RASH (6 inch wide rash on the opposite side of the L elbow (volar area)). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 milligram. On 09-Jan-2021, VACCINATION SITE MOVEMENT IMPAIRMENT (Difficulty moving his L arm up and down) and VACCINATION SITE SWELLING (Painful bump/swelling at the injection site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itchy on the area of the injection) and VACCINATION SITE RASH (6 inch wide rash on the opposite side of the L elbow (volar area)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt had syncopal episode and seizure following first dose of covid vaccine, resulting in calling 911, transferred to the ED
itchy; redness which got bigger; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 20-Feb-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of PRURITUS (itchy) and ERYTHEMA (redness which got bigger) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced ERYTHEMA (redness which got bigger). On 19-Feb-2021, the patient experienced PRURITUS (itchy). At the time of the report, PRURITUS (itchy) and ERYTHEMA (redness which got bigger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was included Tylenol.   Reporter did not allow further contact